Nuclear Medicine in Clinical Oncology: Current Status and Future Aspects

Front Matter....Pages I-XVII
Front Matter....Pages 1-1
Nuclear Oncology: Current Role and Future Direction....Pages 3-9
Nuclear Principles of Tumor Detection....Pages 10-13
Mechanisms Responsible for Radioactive Tracer Uptake in Malignancies....Pages 14-24
Front Matter....Pages 25-25
Gamma Camera Imaging and Single Probe Detection of Tumors....Pages 27-30
Single Photon and Positron Emission Computerized Tomography in Tumor Diagnosis....Pages 31-32
NMR Tomography of Cancer: Technical Considerations....Pages 33-35
Parameter-Selective Proton NMR Imaging and Tissue Characterization In Vivo....Pages 36-38
Development of Magnetic Resonance Contrast Media for Tumors....Pages 39-46
Computer-Assisted Echographic Tissue Characterization in Tumor Diagnostics....Pages 47-51
Front Matter....Pages 53-53
Clinical Aspects of Detection and Imaging of Brain Tumors....Pages 55-59
Noncontact Eye Tumor Imaging with a Gamma Camera....Pages 60-65
Clinical Aspects of Detection and Imaging of Differentiated Thyroid Tumors....Pages 66-73
Clinical Aspects of Detection and Imaging of Lung Tumors....Pages 74-79
Clinical Aspects of Detection and Imaging of Tumors of Liver and Spleen....Pages 80-87
Use of Scintigraphy for Evaluation of Patients with Renal Malignancies....Pages 88-93
Scintigraphy of Lymphokinetics and Lymphatic Neoplasia....Pages 94-107
Bone Scintigraphy in Primary Malignant Bone Tumor....Pages 108-114
Scintigraphic Detection of Bone Metastases....Pages 115-121
Metaiodobenzylguanidine in the Diagnosis of Neuroblastomas....Pages 122-128
Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG)....Pages 129-137
Front Matter....Pages 53-53
Nuclear Medicine in the Diagnosis of Skin Tumors....Pages 138-142
Front Matter....Pages 143-143
Principles of Radioimmunodetection of Tumors....Pages 145-149
Immunoscintigraphy of CEA-Producing Tumors with Special Emphasis on the Use of Mab Fragments and ECT....Pages 150-155
Beta-hCG and Related Germ Cell Tumor Antigens in Radioimmunodetection....Pages 156-163
Radioimmunodetection with Monoclonal Antibodies Against Prostatic Acid Phosphatase....Pages 164-170
Immunoscintigraphy of Ovarian Cancer by Means of HMFG2 Monoclonal Antibody....Pages 171-176
Immunoscintigraphy of Gynaecological Tumors....Pages 177-186
Radioimmunoscintigraphy by Means of Melanoma Antibody....Pages 187-196
Radioimmunoscintigraphy of CA 19-9/CEA Producing Tumors Using I-131 Labeled F(ab′) 2 Fragments of Monoclonal Antibodies (19-9/Anti-CEA Radioimmunococktail)....Pages 197-206
Radioimmunodetection of Malignant Melanoma with Radiolabelled ( 131 I, 123 I, 111 In, 99m Tc) Monoclonal Antibodies and F(ab′) 2 Fragments....Pages 207-214
Imaging of Bone and Soft Tissue Tumors Using an Antitumor Monoclonal Antibody....Pages 215-222
Front Matter....Pages 223-223
Current Status of Magnetic Resonance Imaging of the Central Nervous System....Pages 225-228
NMR Imaging of Tumors in the Body Stem....Pages 229-237
NMR In Vivo Spectroscopy in Tumor Diagnosis....Pages 238-244
Front Matter....Pages 245-245
Production and Use of Positron-Emitting Test Substances for Tumor Diagnosis....Pages 247-249
Uptake of 11 C-Aminocyclopentane Carboxylic Acid (ACPC) and 13 N-Ammonia in Malignant Tumors A Comparative Clinical Study....Pages 250-253
Analysis of Brain Tumor Physiology by Positron Emission Tomography....Pages 254-258
Front Matter....Pages 259-259
Overview of the Development of Tumor Markers....Pages 261-270
The Clinical Value of Tumor-Associated Proteins in Gastrointestinal Cancer....Pages 271-278
The Value of Tumor Markers in the Diagnosis of Urogenital Carcinoma....Pages 279-283
Front Matter....Pages 259-259
Tumor Markers for Monitoring Therapy in Lung Cancer....Pages 284-293
Tumor Markers for Follow-Up of Thyroid Carcinoma....Pages 294-304
Use of Tumor Markers for Patient Monitoring in Breast Cancer....Pages 305-305
Tumormarkers for Monitoring Breast Cancer Patients....Pages 306-306
Front Matter....Pages 307-307
Radioiodine Treatment of Thyroid Carcinomas....Pages 309-320
Therapy of the Neuroblastoma with 131 I-MIBG....Pages 321-326
Treatment of Pheochromocytomas with 131 I-Metaiodobenzylguanidine....Pages 327-330
Treatment of Neuroblastoma by 131 I-Metaiodobenzylguanidine ( 131 I-MIBG): Qualitative and Quantitative Scintigraphic Evaluation of the Treatment Effect....Pages 331-336
Endolymphatic Radionuclide Therapy (ELRT) in Malignant Melanoma of the Lower Extremities....Pages 337-344
On the Efficacy of Strontium-89 Therapy. Preliminary Evaluation of a Double-blind Study....Pages 345-347
Cancer Treatment with Radioactive Labeled Antibodies....Pages 348-361
Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids....Pages 362-364
Treatment of Hepatic Malignancies by Intravascular Administration of Radioisotopes....Pages 365-371
Treatment of Local Prostatic Cancer by 125 Iodine Seeds....Pages 372-377
CT-Guided Stereotactic Implantation with Iridium-192 and Iodine-125 of Non-Resectable Intracranial Tumors....Pages 378-380
Front Matter....Pages 381-381
Radioimmunodetection of Hodgkin Tumors in Nude Mice....Pages 383-390
Immunoscintigraphy of Human Pancreatic Carcinoma in Nude Mice with F(ab′) 2 Fragments of Monoclonal Antibodies to CA 19-9 and CEA....Pages 391-396
Physico-chemical Properties and Biokinetics of Tumor-Affine Metal (M)-Ligand-Complexes....Pages 397-401
Iodoazomycin Riboside [l-(5′-iodo-5′- deoxyribofuranosyl)-2-nitroimidazolel, a Hypoxic Cell Marker In Vivo Evaluation in Experimental Tumors....Pages 402-407
The Potential Use of Alpha and Auger-Electron Emitting Radionuclides for Therapy....Pages 408-412
Front Matter....Pages 381-381
Studies on the In Vivo Stability of 211 At Labelled Albumin Particles in Mice....Pages 413-415
Back Matter....Pages 417-420